Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >

New Research: Could Organ Recipients Forgo Anti-Rejection Medication?

PROGRAM DETAILS:

Kidney transplant recipients currently must take immune-suppressing medications to prevent organ rejection, which can make them vulnerable to infections and disease. In this podcast, Dr. Joseph Leventhal explains ongoing clinical trials at Northwestern that focus on eliminating the need for anti-rejection medication by convincing the patient’s immune system to recognize the new organ as a native part of the body. One clinical trial participant, Lindsay Porter, now post-transplant and doing well, shares her story about how she benefited from this ground-breaking research.

Get Email Updates:

Get updated automatically when new content about Kidney Disease has been posted.
Privacy Policy
Kidney DiseaseMore Health Topics
EXPERTS & GUESTS:
Joseph Leventhal, MD, PhD Joseph Leventhal, MD, PhD
Transplant Surgeon, Northwestern Memorial Hospital
Joseph Leventhal, MD is a transplant surgeon on the medical staff at Northwestern Memorial Hospital and associate professor of surgery and director of the Living Donor Renal Transplant Program at Northwestern University Feinberg School of Medicine. A member of the Northwestern Medical Faculty Foundation, Dr. Leventhal is board certified in surgery and is responsible for launching the Living Donor Renal... more >

Lindsay  Porter Lindsay Porter,
Kidney Transplant Recipient
Lindsay Porter, 47, was 23 when she lost her mother to a brain aneurysm caused by polycystic kidney disease. Lindsay inherited the disease from her mother and her kidneys grew to 16 pounds as a result of her condition. A transplant was needed and her friend volunteered to be a living kidney donor. Lindsay learned about a clinical trial at... more >

TRANSCRIPT:

RELATED LINKS: